Analyst Ratings for West Pharmaceutical (WST)
WST Rating Summary
WST Price Target Summary
- Highest: $447.00 (BNP Paribas Exane)
- Lowest: $350.00 (BofA Securities)
- Average: $408.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$408.00 (+6.2%)
* Over Last 12-Mos
Rating Score: 9.5 / 10
Percentile Rank: 91%
Avg. $ Target:
$408.00 (+6.2%)
* Over Last 12-Mos
Rating Score: 9.5 / 10
Percentile Rank: 91%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/22/2026 | Morgan Stanley | Kallum Titchmarsh | Upgrade | Overweight (Equalweight) |
400.00 (365.00) |
361.78 (384.02) |
6.15% | Details |
| 9/9/2026 | UBS | Douglas Schenkel | New Coverage | Buy (N/A) |
415.00 (N/A) |
337.75 (384.02) |
13.7% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
